Pharmaceuticals Market in India by 2020: A Healthy Decade

pharmaceuticals market in india

This report begins with the current scenario of Pharmaceutical market in India with current market size and structure, market drivers, challenges and competitive landscape. Chapter 2 highlights factors leading India's emergence as a major global player along with the global pharmaceuticals market overview. The chapter 3 throws light on how the current decade going to remain healthy for the Indian pharmaceuticals Industry followed by Chapter4 regulatory environment stating various laws and regulation effecting Indian pharmaceuticals Industry. The report gives overall feel of how by 2020 the Indian pharma industry is going to grow healthy and going to make its existence noticeable in global pharma Industry.

The Indian pharmaceutical market is highly regulated and fragmented, dominated by private Indian companies. Currently the domestic Indian Pharmaceutical market is valued at US$14.30 billion growing at a healthy double digit CAGR of 13% since 2005-06. The major growth contributors are strong Indian demographics with robust economic YOY growth, increase in affordability of medicines, an increased percentage of disposable income being spent on healthcare and increased penetration of health insurance. Also from the government initiatives side, the government has made public healthcare one of its top priorities by launching policies and programs aimed at making healthcare more affordable and accessible, especially in rural markets.

The global pharmaceuticals market is expected to grow at 7% to 8% CAGR over the next five years, reaching an anticipated US$ 1.7 trillion in 2020, India is going to rank among top 10 global player by 2015 itself. Looking at the immense potential Indian Pharmaceutical industry have, IKON estimates that the current decade will be going to change the prescription in Indian Pharmaceutical industry. India will emerge as a leading global player holding the rank among top 5 major global markets by 2020.

Beneficial to:

Pharma Companies, Investors and Venture Capitalists, Industry Analysts & Consultants, Corporate and Entrepreneurs, Industry association, Education and Government Institutes

Table of Content:

  • 1.1 Background
    • 1.2 Market Structure
    • 1.2.1 Product based
    • 1.2.2 Participant based
    • 1.3 Market Segmentation
    • 1.4 Market Size
      • 1.4.1 Major therapeutic segments driving market growth
      • 1.4.2 Export Import trend
      • 1.4.3 Share of Import Export in Industry Turnover
  • 1.5 Contribution to Indian Economy
  • 1.6 Market Drivers
    • 1.6.1 Indian Economy on Robust Growth Track
    • 1.6.2 Growing Indian Middle Class with Rise in the disposable income 
    • 1.6.3 Sound Technical Capability
    • 1.6.4 Supportive Government Initiatives
    • 1.6.5 The Indian Patent (Amendment) Act 2005
    • 1.6.7 Low cost outsourcing opportunities 
    • 1.6.8 Medical Tourism & Medical Infrastructure
    • 1.6.9 M&A by Indian private Companies
  • 1.7 Market Challenges
    • 1.7.1 Price Controls
    • 1.7.2 R&D Spending
    • 1.7.3 Patents & IPR Issues challenging Indian Pharma Industry
    • 1.7.4 Counterfeiting and Spurious drugs
  • 1.8 Competitive Landscape 
    • 1.8.1 Key Market Players
    • 1.8.2 Top 10 player’s sales turnover & market share (2009-10)
  • 2.1 Global Pharmaceutical Market: at a glance
    • 2.1.1 Overview
    • 2.1.2 Top 20 global therapeutic areas
    • 2.1.3 Key Global Trends
  • 2.2 India’s emergence as major global player
    • 2.2.1 India: A robust economy
    • 2.2.2 India: Among top 10 major global players by 2015
    • 2.2.3 India: A Low cost global outsourcing hub
    • 2.2.4 India: Significant Share in World Export
  • 3.1 A decade of Growth: 2020
    • 3.1.1 Market size by 2020
  • 3.2 Factors will drive growth in current decade
    • 3.2.1 Largest Domestic Market
    • 3.2.2 Spending on Drugs & Pharmaceuticals
    • 3.2.3 Penetration of Health Insurance
    • 3.2.4 Booming Indian Healthcare Industry
    • 3.2.5 Shifting pattern of diseases
    • 3.2.6 New emerging sector opportunities
    • 3.2.7 Rise of Tire ii, iii and rural areas
    • 3.2.8 Global Future Market Segments
    • 3.2.9 Rise of Diseases as an Epidemic in India

RESEARCH METHODOLOGY

ABOUT IKON

  • Figure 1: Product Segments
  • Figure 2: Sector contribution in Industry turnover
  • Figure 3: Pharmaceutical market by products/service
  • Figure 4: Pharmaceutical market by Therapeutics
  • Figure 5: Indian Pharmaceutical Market
  • Figure 6: International Trade of Drugs & Pharmaceuticals in India
  • Figure 7: Share of international trade industry turnover
  • Figure 8: India real GDP growth rate
  • Figure 9: India monthly disposable income
  • Figure 10: US-FDA approved plants in India
  • Figure 11: India advantage for outsourcing opportunities
  • Figure 12: Global Pharmaceutical Market
  • Figure 13: GDP growth rate in emerging economies
  • Figure 14: Top 10 global pharma markets by 2015 
  • Figure 15: Top 15 major export players
  • Figure 16: Indian pharma industry by 2020
  • Figure 17: India population in coming decades
  • Figure 18: Heath insurance coverage in India
  • Figure 19: India Health insurance penetration in current decade
  • Figure 20: Hospital market in India
  • Table 1: Patent Application in Indian Pharma sector
  • Table2:Top 10 Major Indian Applicants for patents from Pharmaceutical industry (2009-10)
  • Table 3: Key recent M&A
  • Table 4: The leading pharmaceutical market players in India
  • Table 5: Top 10 player’s sales turnover and market share (2009-10)
  • Table 6: Top 20 global therapeutic areas

Buy this Market Insight


View All Market Insights




RELATED NEWS


the economic times
Indian pharma industry to be in global top 5 by 2020: Ikon Marketing Consultant
the hindu business line
Indian pharma industry to be in global Top 5 by 2020: Study
clinical research society
Indian pharma industry expected to emerge amongst the Top 5 by 2020